Get the latest Science News and Discoveries

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

The work underpinned an Alzheimer's drug by Cassava, now in a Phase III trial.

None

Related news:

Combining psychological factors and biomarkers shows promise in Alzheimer's prediction

Alzheimer's Risk Is Strongly Shaped by Your Mother's Side, Study Finds

U.S. levels fraud indictment at CUNY scientist who helped Alzheimer’s drug developer